ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 224 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $4,457,000 | -85.0% | 316,293 | -74.2% | 0.01% | -79.5% |
Q1 2022 | $29,717,000 | -8.7% | 1,226,971 | -12.0% | 0.04% | 0.0% |
Q4 2021 | $32,556,000 | +36.8% | 1,394,839 | -2.7% | 0.04% | +34.5% |
Q3 2021 | $23,801,000 | -32.4% | 1,432,958 | -0.8% | 0.03% | -31.0% |
Q2 2021 | $35,224,000 | -12.4% | 1,444,182 | -7.3% | 0.04% | -17.6% |
Q1 2021 | $40,191,000 | -44.7% | 1,557,800 | +14.7% | 0.05% | -42.7% |
Q4 2020 | $72,634,000 | +76.6% | 1,358,670 | +36.3% | 0.09% | +53.4% |
Q3 2020 | $41,124,000 | -36.1% | 996,942 | -25.0% | 0.06% | -43.7% |
Q2 2020 | $64,403,000 | +20.6% | 1,328,709 | +5.1% | 0.10% | -9.6% |
Q1 2020 | $53,411,000 | -4.2% | 1,264,168 | -3.0% | 0.11% | +16.3% |
Q4 2019 | $55,765,000 | +0.1% | 1,303,540 | -15.7% | 0.10% | -6.7% |
Q3 2019 | $55,684,000 | +34.0% | 1,547,205 | -0.5% | 0.10% | +36.4% |
Q2 2019 | $41,556,000 | +36.7% | 1,554,658 | +37.4% | 0.08% | +28.3% |
Q1 2019 | $30,390,000 | +644.3% | 1,131,829 | +348.2% | 0.06% | +566.7% |
Q4 2018 | $4,083,000 | – | 252,518 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |